• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先前接受过卡泊芬净治疗的血液恶性肿瘤患者是导致随后发生念珠菌属真菌血症的危险因素:法国巴黎的一项病例对照研究。

Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: a case-control study in Paris, France.

机构信息

INSERM U 657, Paris, France.

出版信息

Antimicrob Agents Chemother. 2011 Nov;55(11):5358-61. doi: 10.1128/AAC.00690-11. Epub 2011 Aug 22.

DOI:10.1128/AAC.00690-11
PMID:21859944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3194997/
Abstract

Infections due to caspofungin-resistant Candida isolates in patients exposed to caspofungin therapy are increasing. We report here a nested case-control study which aimed at identifying factors associated with bloodstream infections caused by Candida spp. having reduced susceptibility to caspofungin (CRSC) in adults suffering from hematological malignancies. In univariate and multivariate analyses, infections with CRSC were associated with caspofungin exposure in the previous 30 days (odds ratio [OR] = 5.25; 95% confidence interval [95% CI], 1.68-16.35) and with an age of ≤ 65 years (OR = 3.27; 95% CI, 1.26-8.50).

摘要

在接受卡泊芬净治疗的患者中,由对卡泊芬净耐药的念珠菌分离株引起的感染正在增加。我们在此报告一项巢式病例对照研究,旨在确定与血液感染相关的因素,这些感染是由患有血液恶性肿瘤的成年人中对卡泊芬净(CRSC)敏感性降低的念珠菌引起的。在单因素和多因素分析中,与 CRSC 感染相关的因素是在过去 30 天内暴露于卡泊芬净(比值比 [OR] = 5.25;95%置信区间 [95%CI],1.68-16.35)和年龄 ≤ 65 岁(OR = 3.27;95%CI,1.26-8.50)。

相似文献

1
Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: a case-control study in Paris, France.先前接受过卡泊芬净治疗的血液恶性肿瘤患者是导致随后发生念珠菌属真菌血症的危险因素:法国巴黎的一项病例对照研究。
Antimicrob Agents Chemother. 2011 Nov;55(11):5358-61. doi: 10.1128/AAC.00690-11. Epub 2011 Aug 22.
2
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.对卡泊芬净耐药的热带念珠菌菌株在血液系统恶性肿瘤高危患者中引起突破性真菌血症。
Antimicrob Agents Chemother. 2008 Nov;52(11):4181-3. doi: 10.1128/AAC.00802-08. Epub 2008 Sep 15.
3
Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients.近期接触卡泊芬净或氟康唑影响念珠菌血症的流行病学:一项涉及 2441 例患者的前瞻性多中心研究。
Antimicrob Agents Chemother. 2011 Feb;55(2):532-8. doi: 10.1128/AAC.01128-10. Epub 2010 Nov 15.
4
Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy.在治疗期间出现了一株对卡泊芬净敏感性降低的克柔念珠菌分离株。
Antimicrob Agents Chemother. 2006 Jul;50(7):2522-4. doi: 10.1128/AAC.00148-06.
5
Monotherapy with caspofungin for candidaemia in adult patients with cancer: a retrospective, single institution study.卡泊芬净单药治疗成年癌症患者念珠菌血症:一项回顾性单机构研究。
Int J Antimicrob Agents. 2009 Jul;34(1):95-8. doi: 10.1016/j.ijantimicag.2009.01.006. Epub 2009 Feb 28.
6
Candida and candidaemia. Susceptibility and epidemiology.念珠菌与念珠菌血症。药敏性与流行病学。
Dan Med J. 2013 Nov;60(11):B4698.
7
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.念珠菌血症治疗期间因FKS1突变导致光滑念珠菌敏感性降低。
Antimicrob Agents Chemother. 2008 Jun;52(6):2263-5. doi: 10.1128/AAC.01568-07. Epub 2008 Mar 31.
8
Caspofungin for the treatment of candidaemia in patients with haematological malignancies.卡泊芬净治疗血液恶性肿瘤患者的念珠菌血症。
Clin Microbiol Infect. 2010 Mar;16(3):298-301. doi: 10.1111/j.1469-0691.2009.02832.x. Epub 2009 Jun 22.
9
Candida krusei--a serious complication in patients with hematological malignancies: successful treatment with caspofungin.克柔念珠菌——血液系统恶性肿瘤患者的一种严重并发症:卡泊芬净治疗成功
Transpl Infect Dis. 2008 Feb;10(1):66-70. doi: 10.1111/j.1399-3062.2007.00238.x. Epub 2007 May 19.
10
Development of candidemia on caspofungin therapy: a case report.卡泊芬净治疗期间发生念珠菌血症:一例病例报告。
Infection. 2006 Dec;34(6):345-8. doi: 10.1007/s15010-006-5613-7.

引用本文的文献

1
Mechanisms of multidrug resistance caused by an Ipi1 mutation in the fungal pathogen Candida glabrata.光滑念珠菌中Ipi1突变导致多药耐药的机制
Nat Commun. 2025 Jan 25;16(1):1023. doi: 10.1038/s41467-025-56269-z.
2
Pichia kudriavzevii (Candida krusei): A systematic review to inform the World Health Organisation priority list of fungal pathogens.毕赤酵母(克鲁维酵母):一项旨在为世界卫生组织真菌病原体优先次序清单提供信息的系统综述。
Med Mycol. 2024 Jun 27;62(6). doi: 10.1093/mmy/myad132.
3
Candida auris-a systematic review to inform the world health organization fungal priority pathogens list.Candida auris- 一项旨在为世界卫生组织真菌优先病原体清单提供信息的系统评价。
Med Mycol. 2024 Jun 27;62(6). doi: 10.1093/mmy/myae042.
4
Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?解读重症监护病房侵袭性念珠菌病的流行病学:是否可行?
Infection. 2021 Dec;49(6):1107-1131. doi: 10.1007/s15010-021-01640-7. Epub 2021 Jun 16.
5
Treatment of candidemia in a nationwide setting: increased survival with primary echinocandin treatment.全国范围内念珠菌血症的治疗:初始使用棘白菌素治疗可提高生存率。
Infect Drug Resist. 2018 Nov 23;11:2449-2459. doi: 10.2147/IDR.S176384. eCollection 2018.
6
Systemic Antifungal Prophylaxis in Patients Hospitalized in Hematology Units in France: The AFHEM Cross-Sectional Observational Study.法国血液科住院患者的全身性抗真菌预防:AFHEM横断面观察性研究
Infect Dis Ther. 2018 Sep;7(3):309-325. doi: 10.1007/s40121-018-0203-4. Epub 2018 Jun 9.
7
Epidemiology of echinocandin resistance in .棘白菌素耐药性的流行病学研究 于……(原文此处不完整)
Curr Fungal Infect Rep. 2014 Dec;8(4):243-248. doi: 10.1007/s12281-014-0209-7. Epub 2014 Sep 21.
8
Population Structure of Candida parapsilosis: No Genetic Difference Between French and Uruguayan Isolates Using Microsatellite Length Polymorphism.近平滑假丝酵母的种群结构:利用微卫星长度多态性,法国和乌拉圭分离株之间没有遗传差异。
Mycopathologia. 2018 Apr;183(2):381-390. doi: 10.1007/s11046-017-0224-7. Epub 2017 Nov 16.
9
Recurrent episodes of Candidemia due to and with acquired echinocandin resistance.由[具体菌种]引起的念珠菌血症复发及获得性棘白菌素耐药。 (你提供的原文中“due to and ”这里有信息缺失,我按照正常理解补充了“由[具体菌种]引起的”,如果实际不是这样,请根据准确内容修改)
Med Mycol Case Rep. 2016 Dec 7;14:20-23. doi: 10.1016/j.mmcr.2016.12.004. eCollection 2016 Dec.
10
Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study.念珠菌血症患者中定殖念珠菌分离株的治疗后抗真菌耐药性:一项系统性多中心研究的结果
Antimicrob Agents Chemother. 2015 Dec 28;60(3):1500-8. doi: 10.1128/AAC.01763-15.

本文引用的文献

1
Current perspectives on echinocandin class drugs.棘白菌素类药物的最新观点。
Future Microbiol. 2011 Apr;6(4):441-57. doi: 10.2217/fmb.11.19.
2
Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Candida species to anidulafungin, caspofungin, and micafungin.利用流行病学截断值来检测 9 年来念珠菌属对安尼鲁单抗、卡泊芬净和米卡芬净敏感性的变化趋势。
J Clin Microbiol. 2011 Feb;49(2):624-9. doi: 10.1128/JCM.02120-10. Epub 2010 Dec 8.
3
Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009).棘白菌素类和三唑类抗真菌药物对念珠菌属、新型隐球菌和烟曲霉的药敏谱:新 CLSI 临床折点和流行病学切点在 SENTRY 抗菌药物监测计划(2009 年)中用于耐药性特征分析的应用。
Diagn Microbiol Infect Dis. 2011 Jan;69(1):45-50. doi: 10.1016/j.diagmicrobio.2010.08.013.
4
Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients.近期接触卡泊芬净或氟康唑影响念珠菌血症的流行病学:一项涉及 2441 例患者的前瞻性多中心研究。
Antimicrob Agents Chemother. 2011 Feb;55(2):532-8. doi: 10.1128/AAC.01128-10. Epub 2010 Nov 15.
5
Increase in Candida parapsilosis fungemia in critical care units: a 6-years study.重症监护病房近平滑念珠菌血症的增加:一项 6 年的研究。
Mycopathologia. 2010 Oct;170(4):263-8. doi: 10.1007/s11046-010-9322-5. Epub 2010 Jun 4.
6
Breakthrough invasive candidiasis in patients on micafungin.米卡芬净治疗患者发生突破性侵袭性念珠菌病。
J Clin Microbiol. 2010 Jul;48(7):2373-80. doi: 10.1128/JCM.02390-09. Epub 2010 Apr 26.
7
Characterisation of breakthrough invasive mycoses in echinocandin recipients: an evidence-based review.棘白菌素类药物治疗后突破性侵袭性真菌感染的特征:基于证据的综述。
Int J Antimicrob Agents. 2010 Mar;35(3):211-8. doi: 10.1016/j.ijantimicag.2009.09.020. Epub 2009 Dec 29.
8
Caspofungin-non-susceptible Candida isolates in cancer patients.癌症患者中对卡泊芬净不敏感的念珠菌分离株。
J Antimicrob Chemother. 2010 Feb;65(2):293-5. doi: 10.1093/jac/dkp444. Epub 2009 Dec 16.
9
High incidence of Candida parapsilosis candidaemia in non-neutropenic critically ill patients: epidemiology and antifungal susceptibility.非中性粒细胞减少的重症患者中近平滑念珠菌血症的高发病率:流行病学及抗真菌药敏情况
Scand J Infect Dis. 2010;42(2):114-20. doi: 10.3109/00365540903321572.
10
Fungal echinocandin resistance.真菌棘白菌素耐药性。
Fungal Genet Biol. 2010 Feb;47(2):117-26. doi: 10.1016/j.fgb.2009.09.003. Epub 2009 Sep 19.